Bioxodes is a Belgian private company, founded in 2013. The Company has received fundings from both the public and private investors. To date, the Company has raised EUR 13.6 million in private equity and EUR 8.5 million in grants/subsidies from the Walloon Region.



Why invest?

Leadership and expertise with international advisor network

Patent portfolio wholly owned with coverage beyond 2040

First-in-class lead compound with solid preclinical & Phase I clinical data

Discovery program for innovative pipeline to extend value capture beyond thrombo-inflammation

Invest in us
Get in touch and explore our investment opportunities